Page 64 - GTM-2-2

Global Translational Medicine New insights into chronic pain management

44. Chen G, Lee R, Højer AM, et al., 2013, Pharmacokinetic pain syndromes associated with nervous or somatic lesions
drug interactions involving vortioxetine (Lu AA21004), a and development of a new neuropathic pain diagnostic
multimodal antidepressant. Clin Drug Investig, 33: 727–736 questionnaire (DN4)”. Pain, 114: 29–36.
https://doi.org/10.1007/s40261-013-0117-6 https://doi.org/10.1016/j.pain.2004.12.010
45. Spina E, Santoro V, D’Arrigo C, 2008, Clinically relevant 49. Campbell LC, Clauw DJ, Keefe FJ, 2003, Persistent pain and
pharmacokinetic drug interactions with second-generation depression: A biopsychosocial perspective. Biol Psychiatry,
antidepressants: An update. Clin Ther, 30:1206–1227. 54: 399–409.
https://doi.org/10.1016/s0149-2918(08)80047-1 https://doi.org/10.1016/S0006-3223(03)00545-6
46. Katona C, Hansen T, Olsen CK, 2012, A randomized, 50. Baliki M, Schnitzer T, Bauer W, et al., 2011, Brain
double-blind, placebo-controlled, duloxetine-referenced, morphological signatures for chronic pain. PLoS One, 6:
fixed-dose study comparing the efficacy and safety of Lu e26010.
AA21004 in elderly patients with major depressive disorder.
Int Clin Psychopharmacol, 27: 215–223. https://doi.org/10.1371/journal.pone.0026010
https://doi.org/10.1097/YIC.0b013e3283542457 51. Apkarian A, Sosa Y, Sonty S, et al., 2004, Chronic back pain
is associated with decreased prefrontal and thalamic gray
47. Talmon M, Rossi S Pastore A, et al., 2018, Vortioxetine matter density. J Neurosci, 24: 10410–1045.
exerts anti-inflammatory and immunomodulatory effects
on human monocytes/macrophages. Br J Pharmacol, https://doi.org/10.1523/JNEUROSCI.2541–04.2004
175: 113–124. 52. Bennett MI, Attal N, Backonja MM, et al., 2007, Using screening
https://doi.org/10.1111/bph.14074 tools to identify neuropathic pain”. Pain, 127: 199–203.
48. Bouhassira D, Attal N, Alchaar H, et al., 2005, Comparison of https://doi.org/10.1016/j.pain.2006.10.034

Volume 2 Issue 2 (2023) 11 https://doi.org/10.36922/gtm.312